Bionano Genomics raises $10M through stock offering

From GlobeNewswire: 2025-01-03 14:34:26

Bionano Genomics, Inc. has entered into an agreement with institutional investors to purchase 39,682,540 shares of common stock and warrants at $0.252 per share in a registered direct offering. The offering is expected to close on January 6, 2024, with gross proceeds of approximately $10 million. The company plans to use the funds for general corporate purposes, research and development, and working capital. H.C. Wainwright & Co. is the exclusive placement agent for the offering. The offering is pursuant to a shelf registration statement on Form S-3 filed with the SEC.

Bionano Genomics, Inc. is a provider of genome analysis solutions, offering optical genome mapping (OGM) solutions, diagnostic services, and software for researchers and clinicians. The company also provides nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through Lineagen, Inc. d/b/a Bionano Laboratories, diagnostic testing services are offered. The company’s products are for research use only and not for diagnostic procedures. Forward-looking statements in the press release include risks and uncertainties related to the offering and use of proceeds.



Read more at GlobeNewswire: Bionano Announces $10 Million Registered Direct Offering